Dr. Reaume founded Melior Discovery Inc fourteen years ago and built it into a robust self-sustaining drug discovery organization. He subsequently spun off two sister companies with proprietary clinical stage candidates (Melior Pharmaceuticals I, Inc., Melior Pharmaceuticals II, LLC). As he has grown, first Melior Discovery, and then launched and grown the Melior Pharmaceutical companies he has been responsible for raising over $15 MM of investment capital and completed over $40MM in partnering deals including research partnerships with global pharmaceutical companies. He was responsible for spearheading and continues to oversee a complex global development partnership with an Asian pharmaceutical partner.
Dr. Reaume’s previous experience includes leadership roles in drug discovery and business analytics at Pfizer and Cephalon with more than twenty-five years of experience in the pharmaceutical industry.